Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Arterial stiffness and the autonomic nervous system during the development of Zucker diabetic fatty rats.

Cosson E, Valensi P, Laude D, Mesangeau D, Dabire H.

Diabetes Metab. 2009 Nov;35(5):364-70. doi: 10.1016/j.diabet.2009.02.007. Epub 2009 Aug 3.

PMID:
19648048
2.

Motor and sensory nerve conduction velocities in Yucatan minipigs.

Hort-Legrand C, Noah L, Mériguet E, Mésangeau D.

Lab Anim. 2006 Jan;40(1):53-7.

PMID:
16460588
3.

Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity.

Valensi P, Doaré L, Perret G, Germack R, Pariès J, Mesangeau D.

Obes Res. 2003 Jan;11(1):54-64.

4.

In vivo quantification and parametric images of the cardiac beta-adrenergic receptor density.

Delforge J, Mesangeau D, Dolle F, Merlet P, Loc'h C, Bottlaender M, Trebossen R, Syrota A.

J Nucl Med. 2002 Feb;43(2):215-26.

5.

[Hemodynamic consequences of endogenous hyperinsulinism in obese rats with lesions of the ventromedial hypothalamus].

Doaré L, Mesangeau D, Adli H, Germack R, Perret G, Valensi P.

Arch Mal Coeur Vaiss. 2000 Aug;93(8):1015-8. French.

PMID:
10989748
6.
7.

[Erythrocyte rheology and heart hypertrophy in diabetes mellitus].

Valensi P, Mesangeau D, Paries J, Zkhiri F, Garnier M.

J Mal Vasc. 1996;21(3):185-7. French.

PMID:
8965049
8.

The neurosteroid pregnenolone sulfate inhibits membrane anion transport and has natriuretic activity.

Garay RP, Nazaret C, Mesangeau D, Moinet G.

J Hypertens Suppl. 1991 Dec;9(6):S288-9. No abstract available.

PMID:
1668000
9.

CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.

Garay RP, Labaune JP, Mesangeau D, Nazaret C, Imbert T, Moinet G.

J Pharmacol Exp Ther. 1990 Nov;255(2):415-22.

PMID:
2243333
10.

Antiarrhythmic activity of cetiedil and its analogues.

Haring J, Mesangeau D, Huet Y, Aurousseau M.

Int J Clin Pharmacol Ther Toxicol. 1980 Nov;18(11):467-81.

PMID:
6110633

Supplemental Content

Loading ...
Support Center